Zevra Therapeutics
Orlando
About Zevra Therapeutics
Zevra Therapeutics is a development-stage biopharmaceutical company focused on the discovery and development of new, safer therapies in the areas of pain, ADHD, and other CNS diseases. The company’s primary efforts include the development of safer, abuse-resistant opioid pain relievers. Its drug discovery and development platform is based on its proprietary Ligand Activated Therapy (LAT) approach. KemPharm uses its patent-applied technology to improve existing drugs and shorten the development timeline while still maintaining a strong intellectual property position within each therapeutic area.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $273.8M
- Funding stage: IPO
- Last round: Post-IPO Equity (Aug 2024)
- Ticker: nasdaq:ZVRA
- Website: zevra.com
- Phone: 888.958.1253
Industries & Categories
Biotechnology, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/zevra-therapeutics-122163 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.